Default: Thrombosis and Haemostasis

ISSN: 0340-6245

Journal Home

Journal Guideline

Thrombosis and Haemostasis Q1 Unclaimed

Georg Thieme Verlag Germany
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Thrombosis and Haemostasis is a journal indexed in SJR in Hematology with an H index of 188. It has an SJR impact factor of 1,97 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,97.

Thrombosis and Haemostasis focuses its scope in these topics and keywords: factor, human, clinical, atrial, protein, patients, expression, inhibition, thrombosis, validation, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Hematology (Q1)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Thrombosis and Haemostasis

1,97

SJR Impact factor

188

H Index

206

Total Docs (Last Year)

745

Total Docs (3 years)

9184

Total Refs

3116

Total Cites (3 years)

642

Citable Docs (3 years)

3,89

Cites/Doc (2 years)

44,58

Ref/Doc

Aims and Scope


factor, human, clinical, atrial, protein, patients, expression, inhibition, thrombosis, validation, platelets, care, cell, blood, effect, leiden, neonatal, lys, fibrillation, fibrinolytic, plasminogen, v,



Best articles by citations

Platelet kinetics and scintigraphic imaging in thrombocytopenic malaria patients

View more

A novel gene mutation in the 60s loop of human coagulation factor VII -inhibition of interdomain crosstalk

View more

Fibrin glue for wound repair: facts and fancy

View more

IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life

View more

Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy

View more

New developments in anticoagulants: Past, present and future

View more

Circulating levels of inflammatory cytokines (IL-1beta and TNF-a), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies

View more

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities

View more

Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients?

View more

Efficacy of AT in pre-eclampsia: a case-control prospective trial

View more

Superoxide Anion and Hydroxyl Radical Release by Collagen-induced Platelet Aggregation - Role of Arachidonic Acid Metabolism

View more

A Novel Platelet Activating Factor Antagonist, SM-12502, Attenuates Endotoxin-induced Disseminated Intravascular Coagulation and Acute Pulmonary Vascular Injury by Inhibiting TNF Production in Rats

View more
SHOW MORE ARTICLES

Critical residues for ligand binding in blade 2 of the propeller domain of the integrin aIIb subunit

View more

Neuraminidase Injections in Rabbits

View more

Expression of tissue factor pathway inhibitor-2 in murine and human liver regulation during inflammation

View more

Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss

View more

The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis

View more

Occurrence of Amphoterin (HMG1) as an Endogenous Protein of Human Platelets that Is Exported to the Cell Surface upon Platelet Activation

View more

Activation-dependent surface expression of gC1qR/p33 on human blood platelets

View more

Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium

View more

Circulating platelet-derived microparticles in systemic lupus erythematosus

View more

Localization of heparin and low-molecular-weight heparin in the rat kidney

View more

Shear-Induced Platelet Aggregation in Normal Subjects and Stroke Patients

View more

The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement

View more

Comments

No comments ... Be the first to comment!

FAQS